At the European Academy of Neurology Congress in Helsinki, researchers unveiled a groundbreaking blood test that could revolutionize Alzheimer’s disease management by identifying patients with mild cognitive impairment (MCI) likely to progress rapidly to severe…… Ground-breaking Alzheimers blood test...
Two innovative Alzheimer’s drugs, donanemab and lecanemab, have been rejected by the NHS due to their exorbitant cost and limited impact. These are the first treatments to slow the disease, potentially extending independent living, by…… Donanemab and Lecanemab rejected for the NHS...
The UK Government’s Spending Review, announced on June 11, 2025, by Chancellor Rachel Reeves, outlined spending and investment plans through 2029-30, addressing key public service priorities amidst a challenging fiscal environment. While the review did…… 2025 Government Spending Review...
On June 1, 2025, Northamptonshire Fire and Rescue Service launched a campaign offering free home fire safety visits tailored for individuals with dementia, aiming to enhance their safety and provide peace of mind for relatives….… Free Safety Checks by Fire Service...